Treatment Optimization of Brain-injured Warfighters
Prescribed sub-symptomatic adaptable exercise treatment (SAET) is a potential solution that promotes recovery needs following a TBI. SAET has been shown to benefit the mind and body in ways that decrease the severity and frequency of mild TBI (mTBI) symptoms. This study aims to validate SAET as an alternative, adaptabl
| Condition(s) | Mild Traumatic Brain Injury |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Prescribed sub-symptomatic adaptable exercise treatment (SAET) is a potential solution that promotes recovery needs following a TBI. SAET has been shown to benefit the mind and body in ways that decrease the severity and frequency of mild TBI (mTBI) symptoms. This study aims to validate SAET as an alternative, adaptable treatment or SMs with mTBI that focuses on reducing symptoms, improving mental health, increasing physiological functioning, and ultimately returning to duty. The objective of this study is to develop a prescribed exercise treatment program for warfighters with mTBI that can be personalized for SM's needs (i.e., medical and occupational) and is adaptable to various clinical resources (e.g., forward operating bases, rural clinics, and mTBI specialty programs). The key questi |
| Who can participate | Inclusion Criteria: * Active duty, male or female, ages 18 to 55 * History of at least one mTBI sustained more than 1 month ago * Service members (SMs) with ongoing symptoms Exclusion Criteria: * SMs who sustained a TBI of any severity within 1 month of enrollment * History of moderate, severe, or penetrating TBI * Current substance use disorder * History of a neurological disease (e.g., multiple sclerosis, cerebral vascular accident, brain tumor, neurodegenerative disease, or neuro-motor disorder) * An acute orthopedic injury that limits the capacity to complete study procedures |
| Ages | 18 Years to 55 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | United States Naval Medical Center, San Diego |
| Locations | Camp Pendleton, California, United States |
| Start date | 2023-09-27 |
| NCT ID | NCT06561100 |
| Official listing | https://clinicaltrials.gov/study/NCT06561100 |